Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Oct:56:31-37.
doi: 10.1016/j.canep.2018.07.002. Epub 2018 Jul 18.

Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis

Catherine L Callahan  1 , Jonathan N Hofmann  1 , Douglas A Corley  2 , Wei K Zhao  2 , Brian Shuch  3 , Wong-Ho Chow  4 , Mark P Purdue  5
Affiliations
Meta-Analysis

Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis

Catherine L Callahan et al. Cancer Epidemiol. 2018 Oct.

Abstract

Background: Although obesity is an established risk factor for renal cell carcinoma (RCC), it is unclear whether this relationship varies across histologic subtypes.

Methods: We conducted a nested case-control study within the Kaiser Permanente Northern California (KPNC) health care network, and meta-analysis combining our results with those of previously published studies. Our KPNC study included 685 RCC cases [421 clear cell; 65 papillary; 24 chromophobe; 35 other; 141 not otherwise specified (NOS)] and 4266 controls. Subtype-specific odds ratios (ORs) and 95% confidence intervals (CIs) for categories of body mass index (BMI) and were computed from the case-control data using polytomous logistic regression. Findings from this and other relevant studies were combined by meta-analysis using a random effects model.

Results: In the KPNC study, obesity (BMI ≥ 30 kg/m2) was associated with clear cell RCC (OR 1.5, 95% CI 1.1-2.1) and chromophobe RCC (OR 2.5, 95%CI 0.8-8.1), but not with papillary RCC (OR 1.0, 95% CI 0.5-1.9). In meta-analysis including three additional studies, a similar pattern of summary relative risks (SRR) for obesity was observed across subtypes (clear cell: SRR 1.8, 95% CI 1.5-2.2; chromophobe: SRR 2.2, 95% CI 1.3-3.7; papillary, SRR 1.2, 95% CI 0.8-1.6).

Conclusions: These findings support the hypothesis that histologic subtypes of RCC possess distinct etiologic pathways, with obesity important for the development of clear cell and, possibly, chromophobe RCC, but not papillary RCC.

Keywords: Body mass index; Case-control studies; Histology; Meta-analysis; Renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Declarations of interest: none

Figures

Figure 1.
Figure 1.
Summary of meta-analyses of case-control RCC subtype specific odds ratios for overweight and obesity vs. BMI<25kg/m2. Abbreviations: BMI, body mass index; RCC, renal cell carcinoma; Summary Relative Risk; USKC, US Kidney Cancer Study; CEERC, Central and Eastern European Renal Cell Cancer Study; KPNC, Kaiser Permanente Northern California.
Figure 2.
Figure 2.
Summary of meta-analyses of case-only odds ratios (clear cell vs. papillary RCC) for overweight and obesity vs. BMI<25kg/m2. Abbreviations: BMI, body mass index; RCC, renal cell carcinoma; Summary Relative Risk; USKC, US Kidney Cancer Study; CEERC, Central and Eastern European Renal Cell Cancer Study; KPNC, Kaiser Permanente Northern California; SRR, summary relative risk. *Compared BMI>30kg/m2 with BMI<30kg/m2
See this image and copyright information in PMC

References

    1. Hosnijeh FS, Portengen L, Spath F, Bergdahl IA, Melin B, Mattiello A, Masala G, Sacerdote C, Naccarati A, Krogh V, Tumino R, Chadeau-Hyam M, Vineis P, Vermeulen R, Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses, International journal of cancer 138(10) (2016) 2357–67. - PubMed
    1. Chow W-H, Dong LM, Devesa SS, Epidemiology and risk factors for kidney cancer, Nature reviews. Urology 7(5) (2010) 245–257. - PMC - PubMed
    1. Linehan WM, Srinivasan R, Schmidt LS, The genetic basis of kidney cancer: a metabolic disease, Nature reviews. Urology 7(5) (2010) 277–85. - PMC - PubMed
    1. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM, The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours, European urology 70(1) (2016) 93–105. - PubMed
    1. Olshan AF, Kuo TM, Meyer AM, Nielsen ME, Purdue MP, Rathmell WK, Racial difference in histologic subtype of renal cell carcinoma, Cancer medicine 2(5) (2013) 744–9. - PMC - PubMed

Publication types